Fact CheckerSign in

NCT04647409Active, not recruiting

Screening for NAFLD in Flanders

Screening for Non-Alcoholic Fatty Liver Disease (NAFLD) in a General Practitioner Population, in Flanders, Belgium.

Source: ClinicalTrials.gov · Last updated 1 Dec 2025

Brief summary (registry, in English)

In the Belgian adult population more than half, and numbers are still increasing, of the population is overweight or obese. These people are at risk to develop NAFLD. However, we lack epidemiological data in Belgium. Therefore, it is important to do epidemiological studies to investigate NAFLD prevalence and disease severity based on a non-invasive approach and evaluate how patients are to be referred.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
10000 (estimated)
First submitted
26 Nov 2020
Start date
26 Oct 2020
Primary completion date
30 Apr 2025
Lead sponsor
Hasselt University
NCT number
NCT04647409

What you commit to

  • Study type: Interventional
  • Planned participants: 10000
  • From 26 Oct 2020 to the primary completion date, 30 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • secondary causes of steatosis
  • excessive alcohol abuse

Who the study is looking for

  • 18 years or older,
  • able to understand Dutch,
  • able to understand the informed consent

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hasselt University
Coordinator of this site? Confirm its status		HasseltBelgiumUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.